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 Abstract 
 
The remarkable progress in characterizing the human genome sequence, exemplified by the 
Human Genome Project and the HapMap Consortium, has led to the perception that knowledge 
and the tools (e.g., microarrays) are sufficient for many if not most biomedical research efforts. 
A large amount of data from diverse studies proves this perception inaccurate at best, and at 
worst, an impediment for further efforts to characterize the variation in the human genome. Since 
variation in genotype and environment are the fundamental basis to understand phenotypic 
variability and heritability at the population level, identifying the range of human genetic 
variation is crucial to the development of personalized nutrition and medicine. The Human 
Variome Project (HVP; http://www.humanvariomeproject.org/) was proposed initially to 
systematically collect mutations that cause human disease and create a cyber infrastructure to 
link locus specific databases (LSDB). We report here the discussions and recommendations from 
the 2008 HVP planning meeting held in San Feliu de Guixols, Spain, in May 2008.   @Published 2009 
Wiley-Liss, Inc. 
 
 
Key Words: variome, genome, mutation, database, genetic disease 
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 Introduction 
 
The  completion of the consensus sequence of the human genome (Lander, et al., 2001; Venter, 
et al., 2001) ushered in the “post-genomic era” of science – that is, experiments could be 
designed using the reference sequence of the genome without need for additional sequencing 
efforts. Subsequent publication of the human haplotype map, an analysis of sequence diversity in 
270 individuals from 4 ancestral populations (International HapMap Consortium, 2003, 2004; 
Frazer, et al., 2007), provided knowledge for building reagents for further genetic analyses. The 
knowledge and sequence information provided the resources to analyze the genetic contribution 
to virtually all measurable phenotypes. These efforts and the resulting databases complemented 
the long-standing efforts by geneticists to locate, identify, and characterize mutations that cause 
monogenic and polygenic diseases in humans, an effort begun by McKusick and colleagues in 
the 1950s (reviewed in McKusick, 2006) and now catalogued in the Online Mendelian 
Inheritance in Man (http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim; Hamosh, et al., 2005) 
and the Human Gene Mutation Database (http://www.hgmd.cf.ac.uk; Stenson, et al., 2008 ). 
NCBI’s dbGaP (Genotype and Phenotype database - http://www.ncbi.nlm.nih.gov/gap; Mailman, 
et al., 2007), HuGEnet (Human Genome Epidemiology Network - 
http://www.cdc.gov/genomics/hugenet/), EBI’s EGA (European Genotype Archive – 
http://www.ebi.ac.uk/ega/), FINDbase (Frequency of INherited Disorders database; 
http://www.findbase.org; van Baal, et al., 2007) and GAD (the Genetic Association Database 
http://geneticassociationdb.nih.gov/; Becker, et al., 2004), are repositories for data from 
population studies associating genetic variation with phenotypes. Most of these databases are 
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 study-oriented and analyze existing polymorphisms rather than focusing on the discovery of new 
genetic variants. 
 
A large amount of other mutation or gene variation data, however, is likely to exist on servers in 
laboratories scattered throughout the world. Each of these databases may contain valuable data 
for other studies and for the medical practitioner. The Human Variome Project (HVP; 
http://www.humanvariomeproject.org/) was previously proposed to systematically collect 
mutations that cause human disease (Cotton, et al., 2007a; Cotton, et al., 2007b; Ring, et al., 
2006) and create a cyber infrastructure to link locus specific databases (LSDBs). Local experts 
would curate individual LSDBs but each would have similar architecture, ontologies, and data 
elements allowing for interoperability. Links to national and international databases such as at 
the National Center for Biotechnology Information (NCBI - http://www.ncbi.nlm.nih.gov/) and 
the European Bioinformatics Institute (EBI - http://www.ebi.ac.uk/) would consolidate the 
knowledge of the curation done by local experts. We report here the discussions and 
recommendations from the 2008 HVP planning meeting held in San Feliu de Guixols, Spain, in 
May 2008, to further the development of the HVP. 
 
The theoretical rationale for re-sequencing genes from individuals in diverse populations is that 
the existing databases have focused primarily on Europeans and their descendants and are 
therefore a relatively narrow subdivision of the entire range of human genetic diversity. 
Published data supporting a concerted re-sequencing effort for monogenic and complex diseases 
come from independent and unlinked studies: 
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 • The molecular basis of 2393 phenotypes was known as of September 2008 
(http://www.ncbi.nlm.nih.gov/Omim/mimstats.html). Many monogenic diseases are caused 
by different mutations in one gene, and all monogenic diseases are known to have variable 
age of onset, severity and outcome (e.g., McKusick, 2007; Ropers, 2007). Differences in 
monogenic disease phenotype may be caused by variations in location of mutations, by 
modifier genes that interact with the disease causing allele (McKusick, 2007), and by gene-
environment interactions (Ordovas and Corella, 2006). Characterizing causative mutations in 
familial and sporadic cases in diverse populations is warranted for a full understanding of 
each disease. 
 
• The molecular basis of over 3700 other phenotypes are either suspected to be Mendelian 
disorders or are unknown (http://www.ncbi.nlm.nih.gov/Omim/mimstats.html). 
 
• Simple monogenic traits may be caused by different gene variants. The ability to hydrolyze 
lactose as an adult, which is called lactase persistence, occurs in ~30% of the world’s 
population (Lomer, et al., 2008). Expression of the lactase gene post-weaning has been 
associated with a C/T variant at position -13910 from the start of the lactase (LCT) gene in 
Finnish families and 236 individuals from 4 populations (Germany, Italy, South Korea and 
Finland) (Enattah, et al., 2002). However, lactase persistence is associated with a different 
variant (G/C at -14010 from LCT) in Kenyans, Tanzanians, and Sudanese (Tishkoff, et al., 
2007). Other populations with higher percentages of individuals with lactose tolerance have 
not been analyzed (Montgomery, et al., 2007). Variation in amounts of lactose required to 
induce intestinal bloating and diarrhea, severity, and age of onset are observed in reference 
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 populations (lactose intolerant) and in populations where the lactase persistence variants are 
more common (Lomer, et al., 2008; Montgomery, et al., 2007). 
 
• Over 290 studies associating polymorphisms in methylene tetrahyrdofolate reductase 
(MTHFR) with various disease or physiological conditions have been published 
(http://www.cdc.gov/genomics/search.htm -> MTHFR). The most studied variants are 
c.677C>T (p.A222V) and c.1298A>C (p.E429A). Marini et al (2008) recently re-sequenced 
564 individuals of diverse genetic ancestry (Coriell Institute panels -- 
http://ccr.coriell.org/Sections/BrowseCatalog/Populations.aspx?PgId=4) and discovered 14 
nonsynonymous changes including 11 alleles with frequencies <1% along with the common 
alleles p.A222V, p.E429A, and p.R594Q (Marini, et al., 2008). Increased levels of folate 
restored MTHFR activity to the normal range in 4 of the 5 variants. The sequence 
heterogeneity and remediation of enzyme activity by folate supports a greater emphasis on 
the ~600 cofactor dependent enzymes in the human proteome. Since many cofactors are 
derived from diet, such studies may identify individuals who require higher concentrations of 
vitamins for optimal health. 
 
Analyses of populations using HapMap data or their derivative reagents also provide justification 
for the need to re-sequence genes in diverse populations. 
 
• Published HapMap data analyzed by a novel algorithm identified chromosomal regions with 
a high Fst (Fixation index, a measure of population differentiation) between three ancestral 
populations (European, Chinese and African) (Myles, et al., 2008b). These regions encoded 
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 genes involved in carbohydrate metabolism, skeletal development, and pigmentation. Such 
allele frequency differences may explain, for example, the differential effect in incidence of 
obesity and type 2 diabetes between Europeans and Pima Indians who consume similar 
Western diets (Schulz, et al., 2006). 
 
• Twenty-five SNPs linked to 6 chronic diseases in genome wide association studies (GWAS) 
were analyzed in ~1000 individuals from 53 populations (Myles, et al., 2008a). Several risk 
alleles were absent from some populations and several were present at 100% frequency 
indicating that the allele may contribute uniquely to disease in the European population. 
Other polymorphisms in these genes or in other genes within the non-European populations 
are likely to contribute to disease incidence and severity. 
 
• Allele frequencies of 873 tag SNPs in 82 candidate genes involved in hypertension, type 2 
diabetes,  obesity,  dyslipidemia or metabolic syndrome varied in 54 populations (Hancock, 
et al., 2008). Some of these genes were linked to adaptation to cold climates and others likely 
to selection by other environmental factors. Exposure to infectious agents such as malaria 
(Kwiatkowski, 2005), high altitude (Beall, 2007) and the food environment (Perry, et al., 
2007) have also been shown to select for certain genotypes. 
 
• Culture is also known to influence allele frequencies among populations. A gradient of 
genotypes exists from northwest to southeast in Europe (Price, et al., 2008). At a fine 
mapping level, allele frequencies mirror geography, and by inference, national culture, within 
Europe (Lao, et al., 2008; Novembre, et al., 2008). 
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Variation at the genomic and gene levels demonstrates that existing data and reagents will not be 
sufficient to identify genes involved in maintaining health or those that contribute to the 
incidence and severity of disease. The newly initiated 1000 Genomes project 
(http://www.1000genomes.org), which is being organized by an international consortium, will 
employ genome-wide re-sequencing and targeted coding region sequencing in a total of 
approximately 1500 individuals from three human populations: Europeans, Africans, and Asians 
(Lang, 2008; Siva, 2008). Each of these populations will be represented by a number of sub 
populations consisting of approximately 100 individuals including Yoruba in Ibadan, Nigeria; 
Japanese in Tokyo; Chinese in Beijing; Utah residents with ancestry from northern and western 
Europe; Toscani in Italy; and other populations to be determined. The goal of this international 
effort is to characterize alleles with frequencies of approximately 1% genome-wide and less than 
1% in coding regions. The phenotype of individuals sequenced in the project will not be 
analyzed. Hence, these data will be used for improving selection of reagents and designs for 
GWAS and will not be directly focused on identification of disease causing genes. Further 
information is available from the project website referenced above. 
 
 
 
 
The Human Variome Project 
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 The Human Variome Project differs from these other efforts in developing and fostering an 
international effort to systematically identify genes, their mutations, and their variants associated 
with phenotypic variability and indications of human disease. The HVP is an international effort 
linking clinical, medical, and research laboratories for developing knowledge housed within 
linked databases. This knowledge would be accessible to the research and medical communities 
to improve research strategies and clinical medical practice. The key objectives of the project are 
described in Box 1. An example of the need for the HVP as applied to neurological disorders has 
recently been published (Cotton, et al., 2008). 
 
The HVP Planning Meeting conducted concurrent meetings that discussed (i) classifying genetic 
variation from unlinked clinical medicine or research laboratories, (ii) capturing data from 
diagnostic and service laboratories, (iii) assessment of pathogenicity, (iv) data transfer, (v) data 
integration access, (vi) funding and governance, (vii) emerging countries’ initiative and 
involvement, (viii) ethics: existing and anticipated concerns, (ix) attribution and publication, and 
(x) pilot projects (Table 1). Reports for classifying and capturing genetic variation from 
laboratories (i.e., committee reports i and ii) have been combined for sake of brevity. Detailed 
reports for these sessions are provided in the supplementary information. Below are synopses of 
the main outcomes and recommendations. 
 
Classifying Genetic Variation from Unlinked Clinical Medicine, Research, or Service 
Laboratories 
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 The cyber infrastructure for biological data is extensive (Stein, 2008) but still not fully integrated 
or developed. The HVP is relying upon these databases for data element definition, storage, 
management, retrieval, and nomenclature. For example, the NCBI provides a gene-centric index 
for mutation nomenclature, Human Genome Organization (HUGO; http://www.hugo-
international.org/) has a naming scheme for genes, and the Human Genome Variation Society 
(HGVS; http://www.hgvs.org/; Cotton and Horaitis, 2000) provides for naming of mutations. 
The Cancer Bionformatics Grid (caBIG - https://cabig.nci.nih.gov/; Fenstermacher, et al., 2005) 
exemplifies the need for interoperability, common languages, data standards and sharing. In 
addition to the disease-specific (e.g., caBIG) and international databases, LSDBs in individual 
laboratories and institutes exist but are not easily linked to the rest of the bioinformatic 
community. 
 
While the data management infrastructure continues to expand, curated genetic data are 
scattered: no coordinated effort exists to harness and harmonize these efforts, data and 
knowledge. Gene mutation and variation data are generated from and used by diagnostic, 
epidemiological experiments, research laboratories, and clinicians, each of which has different 
missions, ability or willingness to curate information, and resources (Table 2). 
 
Since clinical laboratories are not required or encouraged to deposit genotype or phenotype data 
into publicly available databases, data sharing ranges from complete to none. Efforts to 
encourage and develop ongoing data collection have begun and range from commercial 
enterprises to funded grant programs (Table 3). Each of these programs is developing unique 
solutions for the barriers of time, cost, concerns of patient confidentiality, IRB requirements, 
 
U
N
C
O
R
R
E
C
TE
D
 A
C
C
E
P
TE
D
 A
R
TI
C
LE
Published 2008 by Wiley-Liss, Inc. 
 
 
1
Supporting Information availab e from the editorial office (humu@wiley.com) upon request. 
UNCORRECTED ACCEPTED ARTICLE 
 
Mutation Update        Human Mutations 
         DOI 10.1002/humu.20952 
 
Transglutaminase-1 (TGM1) Gene Mutations in Autosomal Recessive Congenital 
Ichthyosis: Summary of Mutations (Including 23 Novel) and Modeling of TGase-1  
 
Matthew L. Herman1, Sharifeh Farasat1, Peter J. Steinbach2, Ming-Hui Wei1, 3, Ousmane Toure1, 
Philip Fleckman4, Patrick Blake1, 5, Sherri J. Bale6, Jorge R. Toro1 
 
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD  
20892, USA 
2Center for Molecular Modeling, Division of Computational Bioscience, Center for Information 
Technology, NIH, Bethesda, MD, 20892, USA 
3Basic Research Program, SAIC-Frederick Inc., Frederick, MD  21702, USA 
4Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, 
98195, USA  
5Howard Hughes Medical Institute, Chevy Chase, MD 
6GeneDx, Inc, Gaithersburg, MD  20877, USA 
 
†This article is a US government work and, as such, is in the public domain in the United 
States of America. 
Received 27 Sep  2008; revised 27 Oct 2008; accepted 17 Nov 2008 
 
 
 maintenance of quality assurance, and difficulties in obtaining clinical information from referring 
centers. These challenges reinforce the concept that clinical laboratories should not be expected 
to develop and curate public databases. However, clinical laboratories should be expected to 
contribute data. Developing a standard open software suite such as the Leiden Open Variation 
Database (LOVD; http://www.lovd.nl; Fokkema, et al., 2005) for these initiatives will allow 
existing tools, for example the Universal Mutation Database (UMD; http://www.umd.be/; 
Beroud, et al., 2000) software, to query across the cyberspace of LSDBs to retrieve and analyze 
data (Table 3). Relying upon a common database design, language and interoperability will 
enforce quality standards across clinical and research laboratories. Nevertheless, clinical and 
research laboratories may have processes and quality measures which would require a “data 
warning” for select entries or datasets. Some of the issues and requirements to initiate adoption 
of these ideas are described in Box 2. Once these individual LSDBs are developed and curated 
locally, ethically appropriate data elements can be deposited in national or international 
databases (NCBI or EBI). 
 
Pathogenicity and Clinical Utility 
 
Understanding the consequences of genetic variation depends upon the simultaneous collection 
and documentation of phenotypic data for each variant (e.g., Cotton et al., 2007a; Crawford and 
Nickerson, 2005; Kaput, 2008; Kaput et al., 2005; Ring et al., 2006; Taylor et al., 2001). The 
correlation between genome and phenotype (pathogenicity) is the basis for the clinical benefit. 
The two broad principles for assessing pathogenicity or phenotype linked to a genetic variant are 
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 that (i) multiple data elements must be integrated and (ii) data elements and the integration 
process must have standards, validation, quantification and transparency (Box 3). 
 
The omics sciences are now capable of generating large but disparate (e.g., genomic vs 
metabolomic) datasets that may be used in research but also clinical applications. Although 
assessing pathogenicity will be an ongoing, iterative process, several specific recommendations 
are warranted: 
 
Genetic and Genomic Data. Gene marker analysis is an important step in the clinical diagnosis 
of pediatric and adult genetic disorders. The issues associated with clinical genetic testing are 
well recognized for inherited cancer syndromes, where missense variants represent 10-30% of 
test results (e.g., (Eisinger, 2008; Metcalfe, et al., 2008; Stoffel, et al., 2008)). Many of these 
variants are classified as having an uncertain effect unless strong genetic epidemiologic and/or 
functional evidence exists associating them with the syndrome. The Breast Cancer Information 
Consortium (BIC - http://research.nhgri.nih.gov/bic/) classifies BRCA1 and BRCA2 variants as 
pathogenic only if the probability of pathogenicity, usually based on statistical genetic 
approaches is, definitely pathogenic >0.99; likely pathogenic 0.95-0.99; uncertain 0.05-0.949; 
likely not pathogenic/little clinical significance (LCS) 0.001-0.049; neutral or LCS <0.001 (Plon 
et al. 2008). For other genes, there are no standards. For each type of data, old and new, the 
principles of standards, validation, quantification and transparency apply. Many of the expected 
gene variants have not been identified or characterized in world populations. Hence, complete re-
sequencing of a gene proven or suspected to be involved in monogenic and polygenic diseases 
will be required to determine causal linkages between genes and phenotype. 
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Standardizing Existing Clinical Phenotype and Pathology. A fundamental problem with 
assessing phenotypes is the diversity of the underlying molecular pathways that cause disease, 
and as a consequence the heterogeneity in clinical manifestations, age of onset, severity, 
complications, and age of death. Other groups (Kaput, et al., 2005; Kathiresan, et al., 2008; 
Makinen, et al., 2008; Rosenzweig, et al., 2002; Wong, 2006; Zaninotto, et al., 2007) have 
proposed using disease as a classifier (e.g., type 2 diabetes), but rely on quantitative measures of 
phenotype (e.g., fasting glucose, fasting insulin) as a means to reduce subjective assignments of 
disease (Tracy, 2008). Since the HVP seeks to collect data from laboratories and clinics, 
phenotype templates are needed to define ranges of (i) minimum sets of clinical data, (ii) range 
of subset data, and (iii) maximum datasets. Such hierarchical template structures will allow 
scientists in all countries to participate in data and sample collection. Developing the 
LOVD/UMD tools (Table 3 and below) for the HVP will also require a means to validate data 
and data quality prior to implementation across laboratories. Clinical and pathology data 
standards must be developed by experts in each genetic disorder for interpreting the effects of 
genetic variation. 
 
Standards linking in vitro functional studies with clinical results. If a cellular function can be 
established that appears to correlate with the clinical syndrome, then in vitro assays could be 
used to classify whether a variant retains or loses function. Standards for performing and 
interpreting the assays are crucial if these methods are to be accepted as a mechanism for 
classifying variants clinically (Couch et al., 2008). In cancer genetics, the correlation of 
mismatch repair defects with Lynch syndrome (Hereditary Non-Polyposis Colorectal Cancer) is 
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 probably the most well-established example (Ou et al., 2007); even so, the principle that multiple 
data elements must be integrated to achieve classification should be respected. 
 
Computational studies. Multiple studies in recent years have confirmed the value of 
comparative sequence analysis in helping to predict whether a missense variant is pathogenic or 
not (reviewed in Tavtigian et al., 2008). However, the issues of standards, validation, and 
transparency also apply to computational methods. Most importantly, the quality of a multiple 
sequence alignment is critical to their accuracy (Ahola et al., 2006; Ahola et al., 2008). The 
choice of ortholog sequences that is used, the quality of cDNA or genomic data, and the methods 
used to construct the alignment are all important features. 
 
Computational Studies - Predictive Algorithms. Some methods have already been validated 
on curated data sets of variants, establishing their Negative Predictive Value (NPV, the 
proportion of predictions of “neutral” that are actually neutral) and Positive Predictive Value 
(PPV, the proportion of predictions of “pathogenic” that are actually pathogenic) (Chan et al., 
2007; Chao et al., 2008). However, several of the more commonly used algorithms have been 
updated. Algorithms exist for coding region variants and predictions of altered splice sites (Nalla 
and Rogan, 2005; Spurdle et al., 2008). New methods, including both rule-based and machine-
learning approaches, are being developed (Tavtigian et al., 2008), and in the future, algorithms to 
assess other non-coding functions of DNA are anticipated. 
 
Data Transfer and Databasing - Gene and Locus Specific Databases 
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 Historically, gene variation data were first collected for specific gene(s) causing a Mendelian 
disorder or a change in the phenotype. These listings usually were initiated and driven by the 
interests of an expert using the collection for research, clinical or diagnostic applications. 
Currently there are over 700 such LSDBs (http://www.hgvs.org/dblist/glsdb.html; Horaitis et al., 
2007), mostly web accessible. Complete collection and expert curation of gene sequence variants 
and their coupling to phenotypic consequences (if any), will be essential for proper future 
healthcare and research. Data Transfer and Databasing plans are outlined in Box 4. 
 
Integrating Data and Providing Access 
 
The breadth and depth of information available about human variation are rapidly expanding as 
new technologies (e.g., omics and imaging) analyze health and pathogenicities. Uncomplicated 
methods of access are needed for multiple user communities with differing expertise in genetics, 
clinical medicine, nutrition, physiology, and probably the public. Information generated by the 
HVP will have many of those dimensions, ranging from how variants are identified, the type of 
variant, the physiological parameters associated with the variant, and where and how records are 
maintained and accessed. For example, information for rare variants, SNPs, microsatellites, small 
insertions/deletions will range from reports of one variant in one individual, such as might be 
gathered from manual data entry and maintained in medical records, to large-scale screening of 
thousands of genomes in defined populations. How the data are represented will be a challenge 
since information will come from published literature or text-rich resources such as OMIM or 
GeneReviews (http://www.geneclinics.org/profiles/all.html; Pagon et al., 2002), include explicit 
records in LSDBs and/or genome-wide resources such as dbSNP or genome browsers. The scope 
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 of the data, which includes locations of variants on reference sequences to phenotypes in humans 
and model organisms, increases the dimensionality. Hence, the scale of information for human 
genetic variation and linked phenotype can range from a single text document to petabytes of 
raw data derived from sequencing thousands of genomes to a high level of coverage and 
accuracy. Model databases capable of accessing known variants will be developed from pilot 
projects and provide a resource for clinicians, patient advocates, and the public (i.e., education). 
 
Accessing known variants. Given the dimensionality issues and the challenges they represent, 
the HVP will help develop an infrastructure to identify variants relative to a reference standard 
and allow facile linking of data with appropriate tools. Notification schemes would be developed 
to indicate missing data for each variant. The HVP is identifying a progression of doable tasks 
with milestones for each. For example, the HVP will link with one such effort, the on-going 
collaboration among GEN2PHEN (http://www.gen2phen.org), EBI, and NCBI to develop an 
international set of standard Locus Specific Genomic Sequence reference (LRGS/RefSeqGene - 
http://www.gen2phen.org/docs/LRG_Specification_Summary_version_9.pdf). With that 
foundation in place, active LSDBs can report their variants in LRG/RefSeqGene coordinates to 
centralized databases (EBI/NCBI) to be accessioned to dbSNP 
(http://www.ncbi.nlm.nih.gov/projects/SNP/; Sherry et al., 2001). The scope of information to be 
centralized requires further debate, but could include items described in Box 5. The HVP will 
ensure that other standards in addition to the reference sequence are developed and/or used, such 
as human gene nomenclature (HUGO Gene Nomenclature Committee (HGNC); 
http://www.genenames.org; Bruford et al., 2008), variant nomenclature (Human Genome 
Variation Society; http://www.hgvs.org/mutnomen; den Dunnen and Antonarakis, 2001), variant 
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 accessions (dbSNP) and names for diseases or diagnostic tests in medical records (Logical 
Observation Identifier Names and Codes, LOINC; e.g., McDonald et al., 2003). Reference gene-
specific standards to support LSDBs and genetic testing groups (see http://www.gen2phen.org 
and http://www.ncbi.nlm.nih.gov/RefSeq/RSG) are under development. In addition, assigning 
accessions in dbSNP to known variants, either directly to dbSNP or Ensembl 
(http://www.ensembl.org), or with PhenCode (http://phencode.bx.psu.edu; (Giardine et al., 
2007)) serving as a data collection center are being implemented. 
 
Public education. With the understanding that large data sets are only as useful as their ease of 
access, the HVP can also foster portal sites to help direct users to tools and resources of interest, 
and identify areas requiring additional development. Tutorials comparing and contrasting 
different resources might also be commissioned. Topics that must be addressed are how to access 
information in the published literature, the effect of variation on transcription, the significance of 
conserved non-coding regions on phenotypic variation, identification of mRNA splice sites, 
descriptions on the structure and maintenance of LSDBs, and strategies for interpreting the 
impact of single (e.g., SNPs) and multiple (e.g., haplotypes) variants in one allele or in multiple 
alleles on the phenotype of interest. The HVP intends to make greater efforts to educate the 
public about the project’s importance and the benefits of research participation. 
 
Attribution and Publication 
 
A major barrier to the development of comprehensive analyses of human genetic variation, and 
therefore LSDBs, is the reward system for clinicians and academic researchers. Non-academic 
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 clinicians typically receive little or no credit for contributing to the scientific literature, and 
academic clinicians and basic researchers cannot easily persuade journals to publish the 50th 
variant of a gene that has an observable effect on phenotype. These cultures may be difficult to 
change overnight, but specific steps could be instituted immediately to promote the submission 
of genotype – phenotype data to LSDBs and to “reward” contributions to team projects. 
Database entries could be a mandatory quality control standard for clinical laboratories and 
clinicians. For researchers, a publication or web-based system establishing micro-attribution and 
community annotation of mutations (e.g., http://www.wikigenes.org) and cited data will enable 
measurable contributions to the scientific knowledge base (Editorial, 2008; Hoffmann, 2008). 
Similarly, database-journals would also serve this task by providing a forum for publishing gene 
variation data that would be eventually deposited in the PubMed literature database. One such 
journal, the open access Human Genomics and Proteomics (HGP; http://www.sage-
hindawi.com/journals/hgp), which is affiliated with FINDbase, will focus on studies 
characterizing causative mutation and/or biomarker frequency spectra. Accepted contributions 
including datasets will be linked in FINDbase and deposited in PubMed (Patrinos and Petricoin, 
2009). Journals, tenure and promotion committees, and funding agencies would be encouraged to 
cite these contributions to and citations of LSDB and international national databases (Patrinos 
and Brookes, 2005). The HVP recommends that researchers cite these attributions and citations 
in their curricula vitae to foster the transition of the academic culture. The same trend and 
recommendations for development of coherent tools are valid for the recognition of contribution 
to the setting, use and sharing of any bioresource such as biobanks (Cambon-Thomsen, 2003; 
Kauffmann and Cambon-Thomsen, 2008) and international efforts like P3G are being developed 
in the same spirit. (Knoppers, et al. 2008) 
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Developing / Emerging Countries – Ensuring a Worldwide Collection 
 
Although ~90% of known SNPs are shared between Asians, Europeans and Africans, 80% of 
private SNPs are found within Asian and Africans (Hinds, et al., 2005; Jorde and Wooding, 
2004). The recent sequencing of the Watson (Wheeler, et al., 2008), Venter (Levy, et al., 2007), 
Kriek (http://www.sciencedaily.com/releases/2008/05/080526155300.htm), West African 
(Bentley et al., 2008) and Han Chinese (Wang et al., 2008) genomes, along with gene specific re-
sequencing efforts (see Introduction), suggest that a large number of SNPs and other sequence 
variation exists in the human population. Estimates from African genetic diversity and the Pan 
Asian SNP initiative suggest that 80 to 90% of human genomic variation resides in the world’s 
emerging countries. Any formal attempt to identify the extent of genomic variation must include 
geographical regions which have not been included in haplotype mapping projects. Although the 
Population Reference Sample (POPRES) will address some of these missing populations (Nelson 
et al., 2008), this effort is designed as a mapping project, not one focused on functional 
polymorphisms or mutations. Hence, the main focus of the HVP effort is the inclusion and 
analyses of clinical samples from diverse ethnic groups. 
 
The distinct advantage of some ethnic populations is the opportunity to study genetic diseases 
due to consanguinity, large family size, and potential founder effects (e.g., Bittles 2001; Bittles 
2002; Saadallah and Rashed, 2007). Emerging nations will be regarded as major contributors to 
the VARIOME project. However, biomedical research has not been the focus of resource poor 
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 countries even though such activities are likely to produce economic and health benefits for all 
(Daar et al., 2002; Singer and Daar, 2001). Education of healthcare providers, the public, and 
government officials is needed for demonstrating the universal nature of the HVP, the need to 
include populations in developing countries, and the benefits from cooperating in biomedical 
research (Bhan et al., 2007; Cohen et al., 2008; Seguin et al., 2008; Tindana et al., 2007). Certain 
populations may mistrust research involving genetic analyses or fear that results can be misused 
to support discrimination or worse (http://www.eubios.info/ASIAE/BIAE201.htm): Malay-
Muslims, Chinese, and Indians in Singapore expressed anxiety about breach of confidentiality, 
the misuse of their DNA for cloning,  and  possibilities of being diagnosed with disease  (Wong 
et al., 2004). Community based participatory research collaborations may provide forums for 
addressing cultural and ethical concerns of biomedical research (McCabe-Sellers et al., 2008). 
 
Analyzing the extent of human genomic variation creates an ideal opportunity for the developed 
and the developing nations of the world to forge meaningful partnerships and to work together in 
an unprecedented way, initially to identify variation causing disease, and then to understand how 
general variation contributes to human phenotypic diversity. By ensuring that all nations and 
ethnic groups have an equal and fair opportunity to share data and technology, we will provide 
evidence-based information that all populations can benefit from a global society health network. 
The primary objectives for including populations in emerging countries are described in Box 6. 
 
The HVP appreciates the genomic sovereignty/equality for all countries to be involved in the 
Human Variome Project and acknowledges the value of ‘human capital’ within all populations. 
Real and tangible benefits of the HVP to improve health will be generated for participating 
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 populations; the voluntary participation of the greatest number of countries would ensure a more 
general applicability and it is hoped that many countries will decide to participate. 
 
Progress in Developing Ethical Guidelines for LSDBs: Principles to Practice to 
Implementation 
 
Ethical issues remain of vital concern to the Human Variome Project. Participating researchers 
are committed to adhering to the highest ethical principles governing research, data sharing and 
ultimately enabling this new knowledge to benefit all of humanity as much as possible. Ethical 
guidelines specifically for LSDBs were previously published (Cotton et al., 2005). 
 
LSDBs may contain a large amount of phenotypic data. Most LSDBs post a considerable amount 
of data on public websites and increasingly this information may be accessible through genome 
browsers. While the best intention of the HVP is to ensure that participants are acknowledged as 
a group, without any risk of identification, a specific challenge occurs in the case of rare 
mutations associated with distinctive clinical features. Since epistatic and environment 
interactions (reviewed in Kaput, 2008) alter age of onset, severity, complications and outcomes 
for monogenic and polygenic phenotypes, it may be necessary to analyze entire genomes for 
personalized healthcare. Such polygenic analyses generate data that could be used for re-
identifying individual patients (Craig et al., 2008). 
 
Other ethical concerns may be minimized by improving communication about the project and its 
goals through multiple channels such as print and broadcast media, local community outreach, 
 
U
N
C
O
R
R
E
C
TE
D
 A
C
C
E
P
TE
D
 A
R
TI
C
LE
Published 2008 by Wiley-Liss, Inc. 
 
 
1
Su porting Information available from the edito ial office (humu@wiley.com) pon request. 
UNCORRECTED ACCEPTED ARTICLE 
 
Mutation Update        Human Mutations 
        DOI 10.1002/humu.20952 
 
Transglutaminase-1 (TGM1) Gene Mutations in Autosomal Recessive Congenital 
Ichthyosis: Summary of Mutations (Including 23 Novel) and Modeling of TGase-1  
 
Matthew L. Herman1, Sharifeh Farasat1, Peter J. Steinbach2, Ming-Hui Wei1, 3, Ousmane Toure1, 
Philip Fleckman4, Patrick Blake1, 5, Sherri J. Bale6, Jorge R. Toro1 
 
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD  
20892, USA 
2Center for Molecular Modeling, Division of Computational Bioscience, Center for Information 
Technology, NIH, Bethesda, MD, 20892, USA 
3Basic Research Program, SAIC-Frederick Inc., Frederick, MD  21702, USA 
4Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, 
98195, USA  
5Howard Hughes Medical Institute, Chevy Chase, MD 
6GeneDx, Inc, Gaithersburg, MD  20877, USA 
 
†This article is a US gover ment work and, as such, is in the public domain in the United 
States of America. 
Received 27 Sep  2008; revised 27 Oct 2008; accepted 17 Nov 2008 
 
 
 and internet sources such as the HGVS website. The HVP will develop an ethics review 
committee with a subcommittee focused on issues related to LSDB for (i) providing counsel 
when dilemmas arise, (ii) overseeing guidelines, (iii) identifying best practices, (iv) determining 
how best to ensure privacy in all situations, (v) formulating how to handle data for which explicit 
consent does not exist or is not possible to achieve, and (vi) developing a consent form that is 
consistent for all LSDBs but which can be adapted to the requirements of individual countries. 
Such consent would contain, for example, a re-contact clause. The specific recommendation and 
open questions are outlined in Box 7. 
 
The HVP, through its Ethics Working Group, is committed to (i) soliciting, collecting and 
analyzing consent forms in order to develop a model consent form that can provide greater 
consistency across all LSDBs, (ii) seeking the input of relevant clinical genetic societies for 
comment, and (iii) using that input to develop ethical standards for LSDBs. 
 
Funding Mechanisms and Governance 
 
Funding for collecting data of mutations causing single gene disorders has traditionally been 
difficult due to the extreme fragmentation of the field even though mutations affect 60% of all 
individuals in a lifetime (Baird, et al., 1988). The funding possibilities are more likely if the 
international HVP is treated as a concerted effort. Given the limitations of existing knowledge 
(see Introduction and Patrinos and Brookes, 2005), this initiative will benefit research in many 
fields and impact prevention and clinical care of disease. Specific focus areas for developing 
funding streams are described in Box 8. 
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Governance. Those dedicated to assisting themselves and others in their clinics by collecting 
mutation/variants causing inherited disease have in the past acted in isolation; reinventing wheels 
wastes funds and time. The HGVS, formerly HUGO-MDI, was formed to alleviate this problem 
and accelerate the collection and management of information on mutation causing disease(s). 
The HVP was named and initiated to define the aims of this activity (Melbourne in 2006) by an 
extremely high profile group of experts in all types of genetic variation analyses. The Genomic 
Disorders Research Center (Melbourne, Australia; http://www.genomic.unimelb.edu.au) was 
voted as coordinating office, to continue its function of facilitating independent projects started 
at the inception of the centre in 1996. In association with world experts, Deloitte 
(http://www.deloitte.com) developed a business plan, which was approved by the HVP Planning 
Group. The HVP Planning Meeting was a designated activity of this plan and other sections of 
the plan will follow (e.g. board function to oversee the coordinating office’s function and support 
it). The business plan calls for a broadly defined community of interested stakeholders to 
develop the HVP (Box 9). 
 
Open questions that must be resolved in future meetings are (i) the extent of data sharing 
between patient records and research databases, (ii) appropriate descriptions of data elements, 
and (iii) data ownership and confidentiality. 
 
Pilot Projects 
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 The HVP has established a partnership with the International Society for Gastrointestinal 
Hereditary Tumors (InSiGHT; http://www.insight-group.org) to collect and classify a large set of 
missense variants associated with hereditary colorectal cancer. This effort will develop HVP’s 
prototype system for interpreting variants observed in clinical genetic testing (Box 10). InSiGHT 
consists of a multidisciplinary scientists focused particularly on the Mendelian disorders 
predisposing to colorectal cancer (Familial Adenomatous Polyposis, Lynch Syndrome and 
MUTYH related polyposes). This effort is an ongoing project but also a model or pilot for the 
HVP. InSiGHT has conducted several multidisciplinary studies of Hereditary Non Polyposis 
Colon Cancer (HNPCC) patients that (i) require the development of a disease-specific model for 
integrating databases across laboratories, (ii) establish standards for data consistency for 
phenotypes (which include graphic pedigrees), (iii) address confidentiality, and (iv) develop a 
template for consent. Clinicians from multiple countries and regions are contributing and 
committing to the development of these systems. Some of these issues cross disciplinary 
boundaries and are being addressed by other committees of the HVP. The InSiGHT consortium’s 
roadmap includes providing access to clinicians, a vital resource that will serve patients in the 
immediate future, and as a model for other genes and phenotypes. Among the first efforts 
involved uploading large datasets of mismatch repair variants generated by national consortia 
and laboratories into the InSiGHT MMR, a LSDB which uses the LOVD platform. Data transfer 
into a mirrored central database (e.g., NCBI or EBI) is also planned with an initial reciprocal 
agreement with the Health Data Integration project at the Australian CSIRO Centre 
(http://www.ict.csiro.au/HAIL/Abstracts/2004/UmaSrinivasan.htm). Other pilot projects are 
described in Box 11. 
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 Discussion 
 
The vision of the HVP, to catalogue and access all information related to human disease 
variation, is ambitious. One can conceptualize the challenge as a multi-dimensional, fluid matrix, 
with all ~20,000 genes as column headings and rows of potentially thousands of variants as 
descriptors. In addition, third and further dimensions would annotate other biological parameters, 
for example clinical and/or metabolic phenotype, microarray expression, proteomics, protein 
interactions, nutrient intakes, physical activity, and other functional phenotypic and 
epidemiological data. Separate dimensions that must be linked to these variants are the main 
effect of gene – environment interactions (e.g., Lim et al., 2007). These data elements relate to 
the cells in the initial two dimensional matrix since each may affect the genetic expression of the 
mutation or gene variant. These dimensions are domains of knowledge that must be integrated 
for understanding biological processes. 
 
A predetermined bioinformatics structure to accommodate this matrix with forced fields for data 
entry is notionally appealing but practically impossible. The reality is that LSDBs, which capture 
the core information in any one of these domains of information, are developed by experts and 
curated with invaluable skill and experience. To force any change on these individual efforts 
would risk inestimable loss of activity by the curators and threaten data of individuals in 
populations. The challenge then is to integrate the existing and developing information within 
existing databases and public resources into a system based on this matrix of domains – the 
vision of the HVP. 
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 The task of developing “super searching” software to interrogate the global information and 
relate it across the HVP matrix in a user-friendly fashion for enquiry represents a bioinformatics 
challenge already embraced by the numerous national projects (e.g., Stein, 2008). This challenge 
can be met with resources applied to software development or existing applications that allow 
searches to locate all information across all domains of the international data matrix. Hansen’s 
SRS (sequence retrieval system) approach (http://e-hrc.net/hdi/), or the novel Genome Commons 
Navigator (Brenner, 2007), supported the Berkeley Computational Biology Center 
(http://ccb.berkeley.edu/ccb/index.html), both target this concept. The Navigator also seeks to 
provide algorithms for potential interpretation of pathogenicity. 
 
The approaches presented at the HVP planning meeting contribute to this goal of integrating 
biological information. The HVP efforts are also consistent with the newly emerging initiative to 
develop standards for scientific disciplines and research strategies: the MIBBI Project (minimal 
reporting guidelines for biological and biomedical investigations; Taylor, 2007; Taylor et al., 
2008). The challenge to catalogue and access this vast body of information relating to human 
biology and behavior is immense, but the HVP is leading this endeavor through international 
collaborations and harmonized protocols. The development of this network of LSDBs and the 
knowledge they generate and maintain will be beneficial not only for the genetic research 
community, but also for researchers in nutrition, toxicology, teratology, physiology – virtually all 
biological research arenas, but perhaps most importantly for the translation of basic research for 
improving personal and public health. The future is indeed exciting. 
 
 
Disclaimer 
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approved for publication by this agency but it does not necessarily reflect official agency policy. 
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Table 1 
 
Organization of Committee Reports a
 
Committees Meeting in Spain Box b
Capturing and classifying genetic variation  
 Unlinked clinical and research laboratories 2 
 diagnostic and service laboratories 2 
Assessment of pathogenicity  
Data transfer 4, 5 
Data Integration access 4, 5 
Emerging countries 6 
Ethics 7 
Funding and governance 8, 9 
Attribution and Publication  
Pilot Projects, including InSiGHT 10, 
11 
  a See text for details  
b Outlines of each committee report are available in the online Supporting 
Information 
  
   Box 1 describes Key Objectives of the HVP 
   Box 3 outlines Standards, Validation, Quantification, Transparency for data 
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Table 2 
Laboratories Involved in Mutation/Variation Discovery and Use 
Laboratory Mission Quality Assurance a
Curation 
b Database Other 
Diagnostic or 
Reference  Service, no research In place None 
Local, if 
any Cost pressure 
Epidemiology 
or Public 
H lth
Associate existing 
variations to 
h t
Provider 
dependent Population
Local & 
global 
No new variant 
data generation 
Research Generate new knowledge None Individual Local Continuity risk 
 
a. Quality Assurance is required in diagnostic or reference laboratory. QA in epidemiology 
studies would depend on the service provider 
b. Curation would be at the population level in epidemiological studies and the individual 
level in research laboratories. Not all research laboratories would curate variants or 
mutants. 
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Table 3 
 
Examples of Clinical – Research Translational Initiatives with Database Suites 
 
Program Name Agency Mission Method 
 
ARUP 
 
Clinical 
Laboratory 
 
University 
of Utah 
 
Galactosemia 
 
Locus specific 
h
m
 
CETT  
 
Collaboration,  
Education,  
Test 
Translation 
 
NIH Office 
of  
Rare 
Diseases 
 
Collaboration 
between clinical  
laboratory, 
research, and 
d t
 
Clinical laboratories collect phenotypic 
data from clinicians through online forms 
prior to genetic testing.  Genotypic and 
phenotypic data to be placed in a database 
h
m
 
DMuDB 
 
Diagnostic 
Mutation 
Database 
 
Certus 
Technology 
Ltd, UK 
National 
Genetics 
Reference 
Laboratory 
 
Mutation database 
for diagnostic 
genetics services 
 
~5,000 entries including 2,900 BRCA1 
and BRCA2 entries from 12 laboratories 
(851 unique variants, 436 of which are not 
in BIC), HNPCC (827 entries from 9 
labs), and the following unique variants: 
177 MLH1, 178 MSH2, 43 MSH6, 116 
APC, 70 Lowe Syndrome, 38 Sotos 
Syndrome, 150 Cystic Fibrosis, 96 
Neurofibromatosis, and 101 X-Linked 
Retinitis Pigmentosa  
h
e
 
eyeGENE 
 
National 
Opthalmic 
Disease 
Genotyping 
Network 
 
NIH 
National 
Eye Institute 
 
The discovery of 
the genetic causes 
of ocular diseases:  
accurate diagnostic 
genotyping to 
patients with 
inherited eye 
diseases; patient 
information; 
develop 
populations for 
study; develop 
resources; improve
 
Patient meeting minimal clinical criteria 
sign research and a clinical testing consent 
forms, are provided counseling. Clinician 
enters the clinical information into the 
online data fields that populate the 
eyeGENE database, while the clinical 
laboratory enters the genotype 
information. The database is not public 
and is password protected for privacy 
h
/r
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IDbases 
 
Immunodefici
ency Database 
 
Tampere 
University 
Hospital 
 
Establish database 
for every 
immunodeficiency 
or provide links to 
those maintained 
elsewhere. 
 
Maintain 122 public IDbases with 3 under 
construction (2008). These databases 
contain data for 5359 patients, 27 
Immunodeficiency mutation databases are 
maintained by others 
h
_
 
NCCRCG 
 
National 
Coordinating 
Center for the 
Genetics and 
Newborn 
Screening 
Regional 
Collaborative 
Groups
 
American 
College of 
Medical 
Genetics 
 
Develop 
standardized 
laboratory and 
clinical language 
for electronic 
medical records 
that will be 
utilized in 
newborn screening
 
Genotype and phenotype information, 
with long-term follow up of newborn 
screening patients, will be collected on the 
54 conditions with over 150 genes 
h
 
LOVD 
2.0 
 
Leiden Open 
Variation 
Database 
 
LAMP = 
Linux, 
Apache, 
MySQL PHP
 
Leiden 
University 
Medical 
Centre 
 
Software and 
database to 
establish, manage 
and curate a web-
based gene 
specific DNA 
variant database 
(LSDB)
 
Sequence variant data and patient data 
stored separately - variations in several 
genes can be linked to one patient. The 
pathogenicity of each variant can be set by 
submitter and curator, allowing one to 
easily separate disease causing from non-
pathogenic variants. 
h
 
UMD 
 
Universal 
Mutation 
Database® 
 
INSERM - 
Montpellier 
 
Creation of 
relational 
databases that run 
on both Macintosh 
and PC platforms 
and can create 
dynamic HTML 
pages for direct 
 
The UMD software uses the 4th 
Dimension® package from 4D.  The 
UMD central tool can query multiple 
Locus Specific DataBases (LSDB) 
developed with the Universal Mutation 
Database® software 
h
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Box 1 
Key Objectives of the HVP 
 
1. Capture and archive all human gene variation associated with human disease in a central 
location with mirror sites in other countries. Data governance will ensure security and 
integrity through the use of auditing and security technologies but nevertheless allow 
searching across all genes using a common interface. 
2. Provide a standardized system of gene variation nomenclature, reference sequences and 
support systems that will enable diagnostic laboratories to use and contribute to total 
human variation knowledge. 
3. Establish systems that ensure adequate curation of human variation knowledge from gene 
specific (locus specific), country specific, or disease specific database perspective to 
improve accuracy, reduce errors and develop a comprehensive data set comprising all 
human genes. 
4. Facilitate the development of software to collect and exchange human variation data in a 
federation of gene specific (locus specific), country specific, disease specific and general 
databases. 
5. Establish a structured and tiered mechanism that clinicians can use to determine the 
health outcomes associated with genetic variation. This will work as a dialogue between 
those who use human variation data and those who provide them. Clinicians will be 
encouraged to provide data and will have open access to complete variation data. 
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 6. Create a support system for research laboratories that provides for the collection of 
genotypic and phenotypic data together using the defined reference sequence in a free, 
unrestricted and open access system and create a simple mechanism for logging 
discoveries. 
7. Develop ethical standards to ensure open access to all human variation data that are to be 
used for global public good and address the needs of “indigenous” communities under 
threat of dilution in emerging countries. 
8. Provide support to developing countries to build capacity and to fully participate in the 
collection, analysis and sharing of genetic variation information. 
9. Establish a communication and education program to collect and spread knowledge 
related to human variation knowledge to all countries of the world. 
10. Continue to carry out research within the opportunities presented by investigation of 
human genetic variation and to present these findings to users of this information for the 
benefit of all. 
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Box 2 
Developing Interoperable Clinical and Research Locus Specific Databases 
 
1. Security, consent and ethical approval 
2. Develop standards and guidelines for diagnostic labs to address database contribution 
3. Develop quality standards for genotype and interpretation 
4. Develop recommendations for formats for submission of data 
5. Provide models for collecting clinical information 
6. Provide recommendation for funding for database efforts, including bioinformatics 
7. Scalability: can small databases readily handle the output from next gen sequencers? 
8. Laboratory pipeline from instruments to database (LIMS : Database interface) 
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 Box 3 
Standards, Validation, Quantification and Transparency 
 
1. Standards - How data (including clinical, demographic, pathologic, genetic, lifestyle and 
environment, computational, and laboratory) are collected, recorded, and utilized should 
be standardized so that results are as unambiguous as possible to users. 
 
2. Validation - Before conclusions are drawn, new types of data should be compared with 
validated sets of variants that are known to be (or are highly likely to be) pathogenic and 
neutral, respectively. 
 
3. Quantification - Uncertainty exists around all of the data types described above.  That 
uncertainty should be quantified as best as possible.  When properly quantified, results 
from all data can be combined to produce a final probability that a variant is pathogenic. 
 
4. Transparency - Uncertainty can best be addressed when the source and quality of all 
data are known.  Understanding genetic variation will be an ongoing, iterative process.  
Proper reporting of a conclusion regarding pathogenicity will require disclosure of all 
data sources, their quality, the methods of combining them, and the date of the 
conclusion. 
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Box 4 
Data Transfer & Databasing Standards for LSDB 
 
1. Develop a program to recruit curators of LSDBs who have yet to join the HVP. 
 
2. LSDBs will be standardized and use freely available and compatible software packages 
such as Universal Media Disc (UMD) or Leiden Open Source Variation Database 
(LOVD). 
 
3. Develop standard formats for published data by disseminating rules for LSDB 
submission to journals. A new standard of publication should call for as much phenotypic 
data as possible. Similarly, funding agencies should require submission of all gene 
variant data resulting from their support. 
 
4. LSDBs should develop and follow quality standards that are measureable and transparent. 
The HGVS should develop a quality label for LSDBs following all standards. 
 
5. To ensure permanent access, LSDBs should share a copy of their data to central 
repositories (e.g. HGVS, NCBI, EBI, Gen2Phen). In addition, to improve easy access, 
LSDBs should consider automated data exchanges in real time with continuously funded 
national databases (NCBI, EBI). 
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6. LSDBs can include data from expression or other in vitro functional studies, but these 
data should be clearly marked as in vitro. 
 
7. New LSDBs are needed for every gene related to a Mendelian disorder. Lost or 
abandoned LSDBs should be revived. HGVS and the Gen2Phen consortium could play 
an active role here, soliciting new curators as well as finding financial support. 
Duplication of effort should be avoided, but if it occurs, LSDBs with common genes and 
variants should share data and entries. 
 
8. An internationally acceptable database policy statement, covering ethical and privacy 
issues for gene variant and phenotype data collection and sharing, is urgently needed. 
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Box 5 
Data Elements for LSDB 
 
1. HGVS name and historical name(s) of the variant 
2. Data submitter (LSDB or individual researcher) 
3. URL back to data submitter per variant 
4. PubMed UIDs associated with the variant 
5. Number of observations of a variant 
6. MIM number of the disease(s) or phenotype(s) of interest 
7. MIM number of the allele of interest 
8. Clinical interpretation 
9. Clinical or research groups testing for this variant 
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Box 6 
Emerging Populations: Objectives for Inclusion 
 
1. Develop procedures to include neglected, under-resourced clinicians/researchers in 
emerging countries, by creating networks among those of common interest. 
 
2. Recognize the need and challenges for recruiting participants.  Considerable resources are 
needed to ensure an adequate consenting process as well as data collection, both of which 
can be cumbersome. 
 
3. Ensure that the databases and software suite of tools that are being used or developed can 
be utilized by those in an under-capacitated environment, and that the software pipelines 
transfer genotype data easily between clinic and laboratory (e.g. Locus Specific 
Databases [LSDB]). 
 
4. Researchers and their academic institutions will develop an infrastructure in anticipation 
of the Coordinating Centre working with international organizations (UN, UNICEF, 
WHO, OECD) to create a framework to facilitate interactions with national governments 
and regional organizations such as NEPAD (New Programme for Africa’s Development) 
downward through national governments, their Departments of Health, Education, 
Science and Technology, amongst others. 
 
 
U
N
C
O
R
R
E
C
TE
D
 A
C
C
E
P
TE
D
 A
R
TI
C
LE
Published 2008 by Wiley-Liss, Inc. 
 
 
1
Supporting Information available from the editorial office (humu@wiley.com) upon request. 
UNCORRECTED ACCEPTED ARTICLE 
 
Mutation Update        Human Mutations 
         DOI 10.1002/humu.20952 
 
Transglutaminase-1 (TGM1) Gene Mutations in Autosomal Recessive Congenital 
Ichthyosis: Summary of Mutations (Including 23 Nov l) and Modeling of TGase-1 
 
Matthew L. Herman1, Sharifeh Farasat1, Peter J. Steinbach2, Ming-Hui Wei1, 3, Ousmane Toure1, 
Philip Fleckman4, Patrick Blake1, 5, Sherri J. Bale6, Jorge R. Toro1 
 
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD  
20892, USA 
2Center for Molecular Modeling, Division of Computa ional Bioscience, Center for Information 
Technology, NIH, Be e da, MD, 20892, USA 
3Basic Research Pr gram, SAIC-Fred rick I ., Frederick, MD  21702, USA 
4Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, 
98195, USA  
5Howard Hughes Medical Institute, Chevy Chase, MD 
6GeneDx, Inc, Gaithersburg, MD  20877, USA 
 
†This article is a US government work and, as such, is in the public domain in the United 
States of America. 
Received 27 Sep  2008; revised 27 Oct 2008; accepted 17 Nov 2008 
 
 
 5. To ensure that ethical, legal, religious and social issues of emerging countries are 
considered in all portals of the HVP. The HVP will enlist the regulatory/policy arm of 
WHO/UN to acknowledge and deal with issues pertinent to Economic, Educational, 
Ethical, Legal and Social Issues. 
 
6. To foster communication, interaction and research networks between the developing and 
the developed countries. 
 
7. To keep abreast of new analytical methods that may impact or influence the ability to 
maintain confidentiality of data. 
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Box 7 
Ethics Sub-Group Recommendations and Remaining Issues 
 
1. Develop a Common Ethical Framework that governs all aspects of the HVP. This 
guideline will ensure strict privacy protection for all participants and provide guidance 
for optimizing informed consent. It will strive to ensure wide access and information 
sharing, global benefit sharing, while preserving individual country norms, guidelines, 
and legal requirements. It will establish a clear basis on which to protect individuals, 
families, and communities from harm. 
 
2. Curation and all communications about work involved in a particular LSDB must be 
transparent and clear as to the nature, purpose and limits of that particular LSDB. 
 
3. Different types of data must be handled in ethically appropriate manners; including 
prospective, published and archived data. All data must, furthermore, be handled 
according to the conditions under which consent was originally obtained, and privacy 
strictly maintained (see footnote). 
 
4. Ideally, donors should be informed when their data is being transmitted to a LSDB and to 
the Web. However, difficulties in achieving this goal arise.  Is consent required prior to 
transmission? What is the ethically appropriate way to handle this requirement when 
consent is not possible (no re-contact clause, impossible to re-contact, or an individual 
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 has died. If consent for transmission was not part of the original consent, must re-contact 
occur to obtain consent? If consent is not obtained is it unethical to transmit even 
anonymized data, or particular types of anonymized data such as that governing smaller 
more easily identified populations/individuals?). 
 
5. What constitutes appropriate consent for prospective data collection?  
 
6. How ought data which is not tied to consent be handled? That is, in the absence of 
explicit approval or refusal can data be used and if so, ought it to be de-identified or 
anonymized, or not used? 
 
7. Is access to deceased individuals’ information ethically appropriate? Is familial consent 
required if individuals did not authorize access prior to their death? 
 
8. In fostering standardization, there is a need to consistently define ‘de-identified’ and 
‘anonymized’ and ensure consistent use across the LSDBs. 
 
9. Create an Ethics Review Committee that can ensure that the HVP adheres to the utmost 
ethical principles as well as serve as counsel in the event of issues in need of resolution. 
For example, the Committee could determine whether rare mutations ought to have more 
stringent protections than common mutations. 
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 10. Ensure strict protection of privacy in cases of rare mutations in rare disease or unique 
combinations of clinical features, where identification of individuals is at risk. 
 
11. Ensure against harms to vulnerable individuals or groups of individuals, including groups 
defined on the basis of data findings. 
 
12. Disclosure of additional data, even for clinical reasons to medical professionals, cannot 
occur unless prior authorization given by donor in original consent. 
 
13. Define conditions for removal from database. 
 
14. Virtual or actual medical relationships with an enquirer are unwise and are discouraged 
(e.g., a company or person who performs the genetic test should not provide advice on 
the use of the results). 
 
15. Determine the appropriate limits to access within LSDBs to prevent individual 
identification. (ex. Ought parts of the LSDB be password protected?) 
 
16. Consider ethical issues arising from transferring data from LSDB to web browsers; refer 
to the Ethics Committee for consensus building. 
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Box 8 
Development of Justifications for Funding 
 
1. Focus on scientific questions and hypotheses that can be addressed using the variome 
database. For example, finding out what proportion of cases in each single gene disorder 
have unexpected phenotype(s) due to presumably modifier genes will require 
substantially reduced effort when collection is complete, up-to-date and easily accessible, 
and this information will be available at all geographical locations. Provide a flow of data 
from patient via clinician/laboratory and curator to central browsers/databases will be 
automated and seamless. 
 
2. Both gene specific and disease specific programs can be developed when applying for 
funding (i.e. the InSiGHT colon cancer project). 
 
3. Develop plans for grant applications for all venues. For examples, applications to 
international, national, state or province or department, country health departments; 
research agencies (e.g. NIH, NCI, MRC, NHMRC, EC, OECD); charitable organizations, 
foundations,  philanthropic trusts and individuals; companies interested in data 
management and sequence data acquisition. Many of these efforts can be pursued in 
parallel. Successful applications will provide leverage for additional ones. 
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 4. Demonstrate feasibility and productivity of approaches before application (pilot projects). 
The most notable at present is the InSiGHT collaboration and the “Adopt a gene” 
approach. 
 
5. Lobby for general support of the HVP as well as for individual grants. 
 
6. Proceed with systematical implementation of the Adopt a Gene approach, which has now 
been initiated, for funding of curators. 
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Box 9 
HVP Governing Plan to Be Developed with Stakeholders 
 
1. Examine overall governance strategy outside the facilitating activities of the coordinating 
office. 
 
2. Examine the potential use of the term Human Variome Programme to be applied to all 
variation activities outside the initial remit of the Human Variome Project as initiated in 
Melbourne.  For example, the utility of the datasets for genome wide association studies, 
HapMap projects, diagnostics for personalized nutrition and medicine. 
 
3. Evaluate the need for a term or body such as the Human Variome Organisation (HUVO) 
and examine whether Human Proteome Organization (HUPO - http://www.hupo.org/) is 
a satisfactory model both for the “HVProgramme” and HVProject”. 
 
4. Define HVP projects and HVP collaborating projects. The first example of a 
collaboration project will be with the InSiGHT consortium. 
 
5. Develop draft criteria for new HVP initiatives. 
 
6. Develop a HVP international consortium after piloting a project in Australia. 
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 7. Develop a Governance/Strategic working group from the Planning Group and others. 
 
8. Encourage standards in the various facets of the HVP and harmonization if this is not 
possible. 
 
9. Encourage the development of miniature devices for complete genome sequencing. 
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Box 10 
The InSiGHT Committee Description and Plans for the Prototype HVP Pilot 
 
The problem of interpreting the pathogenicity of missense variants is most commonly 
encountered in genetic testing for cancer predisposition syndromes. Genetic testing is commonly 
performed for Hereditary Non-Polyposis Colorectal Cancer (HNPCC, Lynch Syndrome), which 
results from inherited pathogenic mutations in at least four genes responsible for DNA Mismatch 
Repair (MMR). Between 15-30% of MMR variants detected during genetic testing for Lynch 
syndrome are missense, and most are rare and not interpretable regarding pathogenicity 
(Peltomaki and Vasen, 1997). InSiGHT has established committees addressing phenotype, 
curation, virtual histology, and funding, which provide advice and support for the Interpretation 
Committee comprised of experts ranging from clinicians to basic scientists. Its two short-term 
goals are to (i) produce a paper discussing standards for data types, classification, and integration 
and (ii) convene to classify as many variants as possible from various international MMR gene 
mutation databases. The InSiGHT Interpretation Committee is undertaking the following actions: 
 
1. Consolidation of multiple MMR gene databases 
2. Assessment quality standards for phenotypic data, including tumor phenotype 
3. Establishment of standards for clinical, epidemiologic, and pathologic data 
4. Formation of standards for in vitro assays 
5. Standardization and quality assurance methods for computational data and methods 
6. Validation of methods for integrating these multiple data sources 
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 7. Using databases to organize data and allowing access to the biomedical community 
 
Box 11 
Other Pilot and Relevant Projects 
 
1. Kuwait (http://www.al-mulla.org/) established a Molecular Genetics Diagnostic Service 
Division, integrated within a research laboratory, which is focused on delivering state-of-
the-art diagnostic service for the Kuwaiti population. These services provide the research 
laboratory with a unique opportunity to meet probands with various genetic diseases. 
 
2. The Danish National HNPCC system has had 12 months’ experience through the web-
based, but closed Danish Health Data Network (www.sundhed.dk). This model is 
relevant for all genetic diseases. A lesson to date here is that systems are successful 
where the output improves the user’s activity and efficiency. 
 
3. Systems to support public and personal health in nutrition is being developed through two 
international nutrigenomics consortia for type 2 diabetes and micronutrient genetics 
(websites within http://www.nugo.org, free registration). These efforts introduce a 
nutritional domain in the data matrix that relate variants of the relevant genes to nutrition 
profiles. 
 
4. The Rare Metabolic Disease database (RAMEDIS http://www.ramedis.de; Topel, et al., 
2006) serves the needs of specialist metabolic centres, including their clinical 
management, and provides access for an understanding of normal biological processes 
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 often first informed by the study of these rare disorders. These too could be linked into 
the broader HVP plan. The interface of microarray expression data into the HVP plan 
offers yet another very challenging data dense domain, which will need careful 
interpretation with respect to its utility in clinical medicine. 
 
5. The UK has developed the central MutDB some time ago to collect all UK variation data 
and its effect from participating laboratories (http://mutdb.org/; Dantzer, et al., 2005). 
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